Correlation Between Pfizer and Salesforce

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Salesforce at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Salesforce into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and SalesforceCom CDR, you can compare the effects of market volatilities on Pfizer and Salesforce and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Salesforce. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Salesforce.

Diversification Opportunities for Pfizer and Salesforce

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Salesforce is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and SalesforceCom CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SalesforceCom CDR and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Salesforce. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SalesforceCom CDR has no effect on the direction of Pfizer i.e., Pfizer and Salesforce go up and down completely randomly.

Pair Corralation between Pfizer and Salesforce

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Salesforce. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc CDR is 1.34 times less risky than Salesforce. The stock trades about -0.17 of its potential returns per unit of risk. The SalesforceCom CDR is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  2,327  in SalesforceCom CDR on September 1, 2024 and sell it today you would earn a total of  304.00  from holding SalesforceCom CDR or generate 13.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  SalesforceCom CDR

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Pfizer is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
SalesforceCom CDR 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in SalesforceCom CDR are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Salesforce Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Salesforce

The main advantage of trading using opposite Pfizer and Salesforce positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Salesforce can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salesforce will offset losses from the drop in Salesforce's long position.
The idea behind Pfizer Inc CDR and SalesforceCom CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing